Notch controls generation and function of human effector CD8+ T cells

Blood

Volumn 121, Issue 14, 2013, Pages 2638-2646

  Kuijk, Loes M ^a   Verstege, Marleen I ^a   Rekers, Niels V ^b   Bruijns, Sven C ^a   Hooijberg, Erik ^a   Roep, Bart O ^b   De Gruijl, Tanja D ^a   Van Kooyk, Yvette ^a   Unger, Wendy W J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHACD28 ANTIGEN; ALPHACD3 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; DELTA LIKE4 PROTEIN; GAMMA INTERFERON; GAMMA SECRETASE INHIBITOR; GRANZYME B; HLA A2 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MELAN A; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PROTEIN; PROTEIN JAGGED 1; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; NOTCH1 PROTEIN, HUMAN; NOTCH2 PROTEIN, HUMAN;

ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; DENDRITIC CELL; EFFECTOR CELL; EX VIVO STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANTIGEN PRESENTATION; CELL COMMUNICATION; CELL CULTURE; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONOCYTE; NEOPLASM;

ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MART-1 ANTIGEN; MONOCYTES; NEOPLASMS; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 84878264534     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-07-442962     Document Type: Article

References (36)

1. Acuto O, Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol. 2003;3(12):939-951.
2. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009;9(4):271-285.
3. Hendriks J, Gravestein LA, Tesselaar K, et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol. 2000;1(5): 433-440.
4. Cannons JL, Lau P, Ghumman B, et al. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J Immunol. 2001; 167(3):1313-1324.
5. Osborne BA, Minter LM. Notch signalling during peripheral T-cell activation and differentiation. Nat Rev Immunol. 2007;7(1):64-75.
6. Baron M. An overview of the Notch signalling pathway. Semin Cell Dev Biol. 2003;14(2): 113-119.
7. Radtke F, Fasnacht N, Macdonald HR. Notch signaling in the immune system. Immunity. 2010; 32(1):14-27.
8. Huppert SS, Le A, Schroeter EH, et al. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature. 2000; 405(6789):966-970.
9. Adler SH, Chiffoleau E, Xu L, et al. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J Immunol. 2003; 171(6):2896-2903.
10. Eagar TN, Tang Q, Wolfe M, et al. Notch 1 signaling regulates peripheral T cell activation. Immunity. 2004;20(4):407-415.
11. Palaga T, Miele L, Golde TE, et al. TCR-mediated Notch signaling regulates proliferation and IFN-gamma production in peripheral T cells. J Immunol. 2003;171(6):3019-3024.
12. Amsen D, Blander JM, Lee GR, et al. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell. 2004;117(4):515-526.
13. Minter LM, Turley DM, Das P, et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat Immunol. 2005;6(7): 680-688.
14. Ostroukhova M, Qi Z, Oriss TB, et al. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest. 2006;116(4):996-1004.
15. Samon JB, Champhekar A, Minter LM, et al. Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood. 2008;112(5): 1813-1821.
16. Ito T, Schaller M, Raymond T, et al. Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation. Am J Respir Crit Care Med. 2009;180(12):1227-1238.
17. Mukherjee S, Schaller MA, Neupane R, et al. Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J Immunol. 2009;182(12):7381-7388.
18. Cho OH, Shin HM, Miele L, et al. Notch regulates cytolytic effector function in CD81 T cells. J Immunol. 2009;182(6):3380-3389.
19. Maekawa Y, Minato Y, Ishifune C, et al. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat Immunol. 2008;9(10):1140-1147.
20. Wong KK, Carpenter MJ, Young LL, et al. Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD81 cell-dependent mechanism. J Clin Invest. 2003; 112(11):1741-1750.
21. Burrows SR, Kienzle N, Winterhalter A, et al. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J Immunol. 2000;165(11):6229-6234.
22. Garrone P, Neidhardt EM, Garcia E, et al. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med. 1995;182(5): 1265-1273.
23. Hooijberg E, Ruizendaal JJ, Snijders PJ, et al. Immortalization of human CD81 T cell clones by ectopic expression of telomerase reverse transcriptase. J Immunol. 2000;165(8): 4239-4245.
24. Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD81 T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003; 281(1-2):65-78.
25. Pittet MJ, Valmori D, Dunbar PR, et al. High frequencies of naive Melan-A/MART-1-specific CD8(1) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med. 1999;190(5):705-715.
26. Appay V, Dunbar PR, Callan M, et al. Memory CD81 T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8(4):379-385.
27. Varnum-Finney B, Wu L, Yu M, et al. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J Cell Sci. 2000;113(Pt 23):4313-4318.
28. Jafar-Nejad H, Leonardi J, Fernandez-Valdivia R. Role of glycans and glycosyltransferases in the regulation of Notch signaling. Glycobiology. 2010; 20(8):931-949.
29. Yvon ES, Vigouroux S, Rousseau RF, et al. Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. Blood. 2003;102(10):3815-3821.
30. Vigouroux S, Yvon E, Wagner HJ, et al. Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes. J Virol. 2003;77(20): 10872-10880.
31. Napolitani G, Rinaldi A, Bertoni F, et al. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005; 6(8):769-776.
32. Joshi I, Minter LM, Telfer J, et al. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. Blood. 2009;113(8):1689-1698.
33. Helbig C, Gentek R, Backer RA, et al. Notch controls the magnitude of T helper cell responses by promoting cellular longevity. Proc Natl Acad Sci USA. 2012;109(23):9041-9046.
34. Sugimoto K, Maekawa Y, Kitamura A, et al. Notch2 signaling is required for potent antitumor immunity in vivo. J Immunol. 2010;184(9): 4673-4678.
35. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol. 2002;2(2): 116-126.
36. Rutz S, Mordmüller B, Sakano S, et al. Notch ligands Delta-like1, Delta-like4 and Jagged1 differentially regulate activation of peripheral T helper cells. Eur J Immunol. 2005;35(8): 2443-2451.